• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗高血压药布屈嗪的代谢,III。

Metabolism of budralazine, a new antihypertensive agent, III.

作者信息

Ono K, Saito T, Sasano H, Moroi R, Sano M, Akimoto T

出版信息

Xenobiotica. 1979 Apr;9(4):227-36. doi: 10.3109/00498257909038725.

DOI:10.3109/00498257909038725
PMID:483859
Abstract
  1. [14C]Budralazine (I) administered orally to normotensive and spontaneously hypertensive rats showed no significant difference in metabolic fate between the two groups. 2. Peak plasma levels of 14C were 3.6 microgram equiv. of I per ml in both normotensive and hypertensive rats. Approx. 5% of total 14C in the plasma consisted of I within 4 h, but thereafter the parent drug was not detected. Approx. 15% of 14C in the plasma consisted of 1-hydrazinophthalazine within 16 h after the administration. 3. 45% and 37% of the dose of 14C was excreted into urine and faeces within 24 h, respectively. 4. A high retention of 14C in the aorta wall was found and the time course of 14C in the aorta wall was compatible with that of the reduction in blood pressure. The radioactive materials retained in the aorta wall were likely to be I or 1-hydrazinophthalazine, probably the latter, following macroautoradiography in hypertensive rats.
摘要
  1. 给正常血压大鼠和自发性高血压大鼠口服[14C]布屈嗪(I)后,两组之间的代谢命运无显著差异。2. 正常血压大鼠和高血压大鼠血浆中14C的峰值水平均为每毫升3.6微克当量的I。约5%的血浆中总14C在4小时内由I组成,但此后未检测到母体药物。给药后16小时内,血浆中约15%的14C由1-肼基酞嗪组成。3. 24小时内,14C剂量的45%和37%分别排泄到尿液和粪便中。4. 发现主动脉壁中14C有高度滞留,主动脉壁中14C的时间进程与血压降低的时间进程一致。在高血压大鼠中进行宏观放射自显影后,保留在主动脉壁中的放射性物质可能是I或1-肼基酞嗪,可能是后者。

相似文献

1
Metabolism of budralazine, a new antihypertensive agent, III.新型抗高血压药布屈嗪的代谢,III。
Xenobiotica. 1979 Apr;9(4):227-36. doi: 10.3109/00498257909038725.
2
Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 2nd communication: A single oral administration of [14C]nipradilol to spontaneously hypertensive rats.新型抗高血压药物尼普地洛在大鼠体内的药代动力学。第二篇通讯:对自发性高血压大鼠单次口服[14C]尼普地洛。
Arzneimittelforschung. 1985;35(11):1680-4.
3
Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.N,N-二乙基间甲苯酰胺在大鼠体内的吸收、分布、代谢及排泄
Drug Metab Dispos. 1996 Feb;24(2):156-63.
4
Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.新型强心药多巴胺在动物体内的代谢命运。首次通讯:在大鼠、兔子和狗体内的吸收、分布及排泄
Arzneimittelforschung. 1986 Apr;36(4):643-51.
5
Antihypertensive and general pharmacological properties of budralazine.布屈嗪的降压及一般药理特性
Arzneimittelforschung. 1981;31(7):1080-7.
6
Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.抗高血压药物布屈嗪对突触前和突触后α-肾上腺素能的作用。
Arzneimittelforschung. 1981;31(7):1076-9.
7
Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.溶栓剂苄佐那在人体内的代谢转归:与大鼠和犬的比较。
Xenobiotica. 1987 Jul;17(7):881-96. doi: 10.3109/00498258709043998.
8
Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.大鼠单次给药后[14C]依巴斯汀的吸收、分布、代谢和排泄
Arzneimittelforschung. 1994 Apr;44(4):527-38.
9
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
10
Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.新型中枢抑制剂8-氯-6-(邻氯苯基)-1-甲基-4H-三唑并[4,3-α][1,4]苯二氮䓬(三唑仑)的代谢。I. 在大鼠、狗和猴体内的吸收、分布及排泄
Xenobiotica. 1979 Jul;9(7):415-28. doi: 10.3109/00498257909038746.